Glenmark becomes the first company to launch fixed dose combination for Type 2 Diabetes in India General Announcement Filing viewer · member access Original SGX announcement
Glenmark launches Tavulus for COPD treatment in Spain becoming one of the first companies to launch General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives marketing approval for Ryaltris nasal spray in 13 countries General Announcement Filing viewer · member access Original SGX announcement
Proceedings and Scrutinizer's Report of the 43rd Annual General Meeting General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam 1% General Announcement Filing viewer · member access Original SGX announcement
Glenmark concludes post marketing surveillance (PMS) study on Favipiravir in 1000+ COVID patients General Announcement Filing viewer · member access Original SGX announcement
Notice of 43rd Annual General Meeting of the Company for FY 2020-21 General Announcement Filing viewer · member access Original SGX announcement
Submission of Annual Report FY 2020-21 General Announcement Filing viewer · member access Original SGX announcement
Intimation of the date of 43rd Annual General Meeting General Announcement Filing viewer · member access Original SGX announcement
First Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Update on listing of equity shares of Glenmark Life Sciences Limited General Announcement Filing viewer · member access Original SGX announcement
Board Meeting Intimation General Announcement Filing viewer · member access Original SGX announcement
Initial public offering of equity shares of our WOS Glenmark Life Sciences Limited General Announcement Filing viewer · member access Original SGX announcement
Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray General Announcement Filing viewer · member access Original SGX announcement
Filing and approval of the Red Herring Prospectus dated July 19 2021 of our Wholly Owned Subsidiary General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules General Announcement Filing viewer · member access Original SGX announcement
GPL receives ANDA approval for Arformoterol Tartrate Inhalation Solution General Announcement Filing viewer · member access Original SGX announcement
Glenmark launches Tiogiva becoming one of the first companies in the UK General Announcement Filing viewer · member access Original SGX announcement
Glenmark interim data on Favipiravir supports its safety in Covid19 patients General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives ANDA approval for Theophylline Extended Release Tablets General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals launches Rufinamide Tablets General Announcement Filing viewer · member access Original SGX announcement
Full Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Glenmark receives ANDA approval for Icatibant Injection Single Dose Prefilled Syringe General Announcement Filing viewer · member access Original SGX announcement
Glenmark launches Ryaltris -AZ at an affordable price in India General Announcement Filing viewer · member access Original SGX announcement